Esperion Therapeutics Inc (NASDAQ: ESPR) – Suitable For Long Term Buy?
Currently, there are 195.44M common shares owned by the public and among those 195.06M shares have been available to trade. The company’s stock has a 5-day price change of -35.34% and 27.84% over the past three months. ESPR shares are trading -24.75% year to date (YTD), with the 12-month market performance up to 49.01% higher. […]
Esperion Therapeutics Inc (ESPR) Volatility Spurs A Quest For Clarity
Currently, there are 195.44M common shares owned by the public and among those 195.06M shares have been available to trade. The company’s stock has a 5-day price change of -6.46% and 74.71% over the past three months. ESPR shares are trading 1.67% year to date (YTD), with the 12-month market performance up to 104.03% higher. […]
Esperion Therapeutics Inc (NASDAQ: ESPR) – Suitable For Long Term Buy?
Currently, there are 195.44M common shares owned by the public and among those 195.06M shares have been available to trade. The company’s stock has a 5-day price change of 23.02% and 69.40% over the past three months. ESPR shares are trading 3.68% year to date (YTD), with the 12-month market performance up to 133.08% higher. […]
These Numbers Could Change Investor Views For Esperion Therapeutics Inc (NASDAQ: ESPR)
Currently, there are 197.03M common shares owned by the public and among those 195.06M shares have been available to trade. The company’s stock has a 5-day price change of 6.64% and 51.18% over the past three months. ESPR shares are trading -14.05% year to date (YTD), with the 12-month market performance up to 108.94% higher. […]
Growing Through Challenges? – Esperion Therapeutics Inc (ESPR)
Currently, there are 197.03M common shares owned by the public and among those 195.06M shares have been available to trade. The company’s stock has a 5-day price change of -0.82% and 36.93% over the past three months. ESPR shares are trading -19.40% year to date (YTD), with the 12-month market performance up to 102.52% higher. […]
Better Times Ahead For Esperion Therapeutics Inc. (NASDAQ: ESPR)?
Esperion Therapeutics Inc. (ESPR) concluded trading on Wednesday at a closing price of $2.12, with 4.63 million shares of worth about $9.81 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 15.22% during that period and on October 16, 2024 the price saw a […]
Better Times Ahead For Esperion Therapeutics Inc. (NASDAQ: ESPR)?
Esperion Therapeutics Inc. (ESPR) concluded trading on Wednesday at a closing price of $1.93, with 4.01 million shares of worth about $7.73 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -23.41% during that period and on October 09, 2024 the price saw a […]
Set Your Sights On Esperion Therapeutics Inc. (NASDAQ: ESPR)’S Upside Potential
Esperion Therapeutics Inc. (ESPR) concluded trading on Wednesday at a closing price of $1.82, with 6.86 million shares of worth about $12.48 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -41.67% during that period and on October 02, 2024 the price saw a […]
Institutional Exposure To Esperion Therapeutics Inc. (ESPR)
Esperion Therapeutics Inc. (ESPR) concluded trading on Wednesday at a closing price of $2.61, with 4.62 million shares of worth about $12.07 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 76.35% during that period and on Wednesday the price saw a loss of […]
Esperion Therapeutics Inc. (NASDAQ: ESPR) Stock In Prove Me State
Esperion Therapeutics Inc. (ESPR) concluded trading on Thursday at a closing price of $2.66, with 2.99 million shares of worth about $7.95 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 73.86% during that period and on Thursday the price saw a gain of […]
